Trends shaping the veterinary market
Veterinary Record · 15.06.2024 · 194 (12) · 467-467
DOI: 10.1002/vetr.4416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 14.06.2024.
Abstract (Originalsprache)
BUSINESS property adviser Christie & Co has launched its Veterinary Market Insight 2024 report, analysing trends that it says have shaped the UK vet sector over recent years. Between 2021 and 2024, the company valued over 150 veterinary practices across the UK with a combined total value of £222 million. It reports around a 70 per cent increase in the value of practices it has valued since 2021, which it says could be attributed to the increase in animal ownership figures and the demand for veterinary services. While the report showed a 6.13 per cent rise in the average gross profit margins of practices between 2021 and 2023, it highlighted an average fall in EBITDA (earnings before interest, tax, depreciation and amortisation) of around 3 per cent between 2021 and 2022. However, it says these levels increased between 2022 and 2023 as practices successfully increased their topline turnover. Looking forward to 2024/25, the company predicts continued growth in UK pet ownership with further demand for veterinary services. It also says it expects vet practices to diversify and offer more specialist services to capture a larger client base. It believes that advances in technology and artificial intelligence could impact the veterinary market, but says to what extent is unclear. www.christie.com/news-resources/publications/veterinary-market-insight-2024/
Zitieren
APA
(2024). Trends shaping the veterinary market. Veterinary Record, 194(12), 467-467. https://doi.org/10.1002/vetr.4416
Vancouver
Trends shaping the veterinary market. Veterinary Record. 2024;194(12):467-467. doi:10.1002/vetr.4416
BibTeX
@article{euvimed2024,
title = {Trends shaping the veterinary market},
journal = {Veterinary Record},
year = {2024},
volume = {194},
number = {12},
pages = {467--467},
doi = {10.1002/vetr.4416}
}
EUVIMED